Aug 14, 2023 / 08:30PM GMT
Operator
Good afternoon, and welcome to the INVO Bioscience second-quarter fiscal year 2023 financial results conference call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Robert Blum of Lytham Partners. Please go ahead.
Robert Blum - Lytham Partners - IR
Great. Thanks so much, Kate. Good afternoon, everyone, and thank you, all, for joining us for INVO Bioscience's second-quarter 2023 financial results conference call.
Joining us on the call today are INVO Bioscience's CEO, Steve Shum; the company's Chief Operating and VP of Business Development, Mike Campbell; and Andrea Goren, the company's Chief Financial Officer. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session.
Before we begin with the event, we submit for the record the following statement. Certain matters discussed on this conference call by the management of INVO Bioscience may be forward-looking statements within the meaning of Section 27A of the Securities Act
Q2 2023 INVO Bioscience Inc Earnings Call Transcript
Aug 15, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers